Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention

References

• Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, Jaffe AS, Jneid H, Kelly RF, Kontos MC, et al. 2014 AHA/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes: A report of the American college of cardiology/American heart association task force on practice guidelines. doi:10.1161/CIR.0000000000000134
   Google Scholar
• Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, et al. ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardio-Thoracic Surg 2017;August:213–254. doi:10.1093/ejcts/ezx334.
   Google Scholar
• Gurbel PA, Bliden KP, Butler K, Antonino MJ, Wei C, Teng R, Rasmussen L, Storey RF, Nielsen T, Eikelboom JW, et al. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study. 2010 [accessed 2018 Nov 30]. http://circ.ahajournals.org. doi:10.1161/CIRCULATIONAHA.109.919456
   Google Scholar
• Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, S V M, Feit F, et al. Acute Coronary Syndromes A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes. 2010 [accessed 2018 Sep 4]. https://ac.els-cdn.com/S073510971001288X/1-s2.0-S073510971001288X-main.pdf?_tid=27caf626-8e0a-4321-b72a-1a75a23490ca&acdnat=1536078947_589f66ac6c2ed715956b80c80f985f7d. doi:10.1016/j.jacc.2009.09.076
   Google Scholar
• Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom KJ, Gupta A, Messenger JC, Wang TY. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the TRANSLATE-ACS study. Eur Heart J: Acute Cardio Care 2015;accessed 2018Nov 30; 4(6):499–508. http://journals.sagepub.com/doi/10.1177/2048872614564082. doi:10.1177/2048872614564082.
   PubMed Web of Science ®Google Scholar
• Zettler ME, Peterson ED, Mccoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY. Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study. Am Heart J. 2017;183:62-68. doi:10.1016/j.ahj.2016.10.006.
   Google Scholar
• Angiolillo DJ, Rollini F, Storey RF, Bhatt DL, James S, Schneider DJ, Sibbing D, So DYF, Trenk D, Alexopoulos D, et al. International expert consensus on switching platelet P2Y12receptor-inhibiting therapies. Circulation 2017;136(20):1955–1975. doi:10.1161/CIRCULATIONAHA.117.031164.
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. New England J Med 2009;accessed 2018 Aug 28361(11):1045–1057. https://www.nejm.org/doi/pdf/10.1056/NEJMoa0904327 doi:10.1056/NEJMoa0904327.
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, Mccabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann F-J, Ardissino D, De Servi S, Murphy SA, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes A bs t r ac t. 2007 [accessed 2018 Aug 28]. www.nejm.org. doi:10.1056/NEJMoa0706482
   Google Scholar
• Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Mence Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert M, et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. [accessed 2018 Sep 12]. https://academic.oup.com/eurheartj/article-abstract/38/41/3070/3827697. doi:10.1093/eurheartj/ehx253
   Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Eur Heart J 2018;August:1–33. doi:10.1093/eurheartj/ehy462.
   Google Scholar
• F-J N, Sousa-Uva M, Ahlsson A, Alfonso F, Ap B, Benedetto U, Ra B, J-P C, Falk V, Sj H, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2018;August:1–96. doi:10.1093/eurheartj/ehy394.
   Google Scholar
• Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, G-A VE, Steg PG, M-A M, Mauri L, Vranckx P, et al. Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions. 2007 [accessed 2018 Dec 2]. http://www.circulationaha.org. doi:10.1161/CIRCULATIONAHA.106.685313
   Google Scholar
• Mehran R, Rao SV, Bhatt DL, Gibson M, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Special Report Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium. 2011 [accessed 2018 Dec 2]. http://circ.ahajournals.org. doi:10.1161/CIRCULATIONAHA.110.009449
   Google Scholar
• Granger CCB, Goldberg R, Dabbous O, Pieper K, Eagle K, Cannon C, Werf F, Van De, Avezum A, Goodman S, Flather M, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163(19):2345. doi:10.1001/archinte.163.19.2345.
   PubMedGoogle Scholar
• Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, et al. Baseline risk of major bleeding in non-sT-segment- elevation myocardial infarction the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation 2009;119(14):1873–1882. doi:10.1161/CIRCULATIONAHA.108.828541.
   PubMed Web of Science ®Google Scholar
• De Luca L, D’Ascenzo F, Musumeci G, Saia F, Parodi G, Varbella F, Marchese A, De Servi S, Berti S, Bolognese L. Incidence and outcome of switching of oral platelet P2Y12receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry. EuroIntervention 2017;13(4):459–466. doi:10.4244/EIJ-D-17-00092.
   PubMed Web of Science ®Google Scholar
• Clemmensen P, Grieco N, Ince H, Danchin N, Goedicke J, Ramos Y, Schmitt J, Goldstein P. MULTIPRAC study investigators. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel–the European MULTIPRAC Registry. Eur Heart J Acute Cardio Care 2015;accessed 2018 Dec 24(3):220–229. http://journals.sagepub.com/doi/10.1177/2048872614547449 doi:10.1177/2048872614547449.
   PubMed Web of Science ®Google Scholar
• Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Angelidis C, Petousis S, Stakos D, Parissis H, et al. In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome. Am Heart J 2014;accessed 2018Sep 12; 167(1):68–76.e2. https://www.sciencedirect.com/science/article/pii/S0002870313007187?via%3Dihub. doi:10.1016/J.AHJ.2013.10.010.
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Butler K, Antonino MJ, Wei C, Teng R, Rasmussen L, Storey RF, Nielsen T, Eikelboom JW, et al. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study. 2010 [accessed 2018 Sep 5]. http://circ.ahajournals.org. doi:10.1161/CIRCULATIONAHA.109.919456
   Google Scholar
• Roy P, Bonello L, Torguson R, De Labriolle A, Lemesle G, Pinto Slottow TL, Dh S, Kaneshige K, Xue Z, Lf S, et al. Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation. AJC 1614 accessed 2018Nov 27; 102:1614–1617. www.AJConline.org. doi:10.1016/j.amjcard.2008.07.063.
   Google Scholar